| Rachel Beth Mason, MD | |
|
3901 Rainbow Blvd, 6040 Delp, Ms 1020, Division Of General And Geriatric Medicine, Kansas City, KS 66160-0001 | |
| (913) 588-3974 | |
| (913) 588-6055 |
| Full Name | Rachel Beth Mason |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 15 Years |
| Location | 3901 Rainbow Blvd, 6040 Delp, Ms 1020, Kansas City, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619105467 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 04-35715 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Continua Home Health | Leawood, KS | Home health agency |
| Specialized Home Care | Independence, MO | Home health agency |
| Ahc Home Health Of Kansas City, Llc | Overland park, KS | Home health agency |
| Ascend Hospice | Lees summit, MO | Hospice |
| Crossroads Hospice Of Kansas City, L C | Independence, MO | Hospice |
| Kansas City Hospice And Palliative Care | Kansas city, MO | Hospice |
| Norterre | Liberty, MO | Nursing home |
| New Mark Care Center | Kansas city, MO | Nursing home |
| Tiffany Springs Rehabilitation & Health Care Cente | Kansas city, MO | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Curana Health Of Missouri-kansas Llc | 4789716531 | 66 |
| Curana Health Of Missouri-kansas Llc | 4789716531 | 66 |
| Empowerme Wellness Kansas City Llc | 9830504836 | 99 |
| Legacy Healthcare Services Inc | 2163339722 | 2654 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.
Researchers from BWH have uncovered a new genetic cause for erythropoietic protoporphyria (EPP), a photosensitive blood disorder. In the past, the most well-known causes for EPP were two specific genetic disorders, but using an extended pedigree from France, the investigators found that EPP can also be caused by changes in another gene.
On January 24, 2013, Iris Vega-Figueroa's life changed completely. That's the day she gave birth to her twin girls, Iris and Geraldine. The twins were monoamniotic-monochorionic, meaning they shared one amniotic sack and one placenta in the womb. These rare pregnancies are considered high risk because of the uneven blood flow that occurs between the infants through the placenta.
Meanwhile, the Associated Press checks on the status of the online insurance markets in the District of Columbia, New York, New Mexico and South Carolina.
› Verified 9 days ago
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.
Researchers from BWH have uncovered a new genetic cause for erythropoietic protoporphyria (EPP), a photosensitive blood disorder. In the past, the most well-known causes for EPP were two specific genetic disorders, but using an extended pedigree from France, the investigators found that EPP can also be caused by changes in another gene.
On January 24, 2013, Iris Vega-Figueroa's life changed completely. That's the day she gave birth to her twin girls, Iris and Geraldine. The twins were monoamniotic-monochorionic, meaning they shared one amniotic sack and one placenta in the womb. These rare pregnancies are considered high risk because of the uneven blood flow that occurs between the infants through the placenta.
Meanwhile, the Associated Press checks on the status of the online insurance markets in the District of Columbia, New York, New Mexico and South Carolina.
› Verified 9 days ago
| Entity Name | Curana Health Of Missouri-kansas Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306165337 PECOS PAC ID: 4789716531 Enrollment ID: O20120621000598 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.
Researchers from BWH have uncovered a new genetic cause for erythropoietic protoporphyria (EPP), a photosensitive blood disorder. In the past, the most well-known causes for EPP were two specific genetic disorders, but using an extended pedigree from France, the investigators found that EPP can also be caused by changes in another gene.
On January 24, 2013, Iris Vega-Figueroa's life changed completely. That's the day she gave birth to her twin girls, Iris and Geraldine. The twins were monoamniotic-monochorionic, meaning they shared one amniotic sack and one placenta in the womb. These rare pregnancies are considered high risk because of the uneven blood flow that occurs between the infants through the placenta.
Meanwhile, the Associated Press checks on the status of the online insurance markets in the District of Columbia, New York, New Mexico and South Carolina.
› Verified 9 days ago
| Entity Name | Ch Specialty Services Ks Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770282188 PECOS PAC ID: 6800261819 Enrollment ID: O20230405000528 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.
Researchers from BWH have uncovered a new genetic cause for erythropoietic protoporphyria (EPP), a photosensitive blood disorder. In the past, the most well-known causes for EPP were two specific genetic disorders, but using an extended pedigree from France, the investigators found that EPP can also be caused by changes in another gene.
On January 24, 2013, Iris Vega-Figueroa's life changed completely. That's the day she gave birth to her twin girls, Iris and Geraldine. The twins were monoamniotic-monochorionic, meaning they shared one amniotic sack and one placenta in the womb. These rare pregnancies are considered high risk because of the uneven blood flow that occurs between the infants through the placenta.
Meanwhile, the Associated Press checks on the status of the online insurance markets in the District of Columbia, New York, New Mexico and South Carolina.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Beth Mason, MD 3901 Rainbow Blvd, 4070 Delp, Ms 4017, Kansas University Physicians Inc, Kansas City, KS 66160-0001 Ph: (913) 588-2501 | Rachel Beth Mason, MD 3901 Rainbow Blvd, 6040 Delp, Ms 1020, Division Of General And Geriatric Medicine, Kansas City, KS 66160-0001 Ph: (913) 588-3974 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has filed a Clinical Trial Application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase I clinical trial with ALN-TTR02, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis.
Researchers from BWH have uncovered a new genetic cause for erythropoietic protoporphyria (EPP), a photosensitive blood disorder. In the past, the most well-known causes for EPP were two specific genetic disorders, but using an extended pedigree from France, the investigators found that EPP can also be caused by changes in another gene.
On January 24, 2013, Iris Vega-Figueroa's life changed completely. That's the day she gave birth to her twin girls, Iris and Geraldine. The twins were monoamniotic-monochorionic, meaning they shared one amniotic sack and one placenta in the womb. These rare pregnancies are considered high risk because of the uneven blood flow that occurs between the infants through the placenta.
Meanwhile, the Associated Press checks on the status of the online insurance markets in the District of Columbia, New York, New Mexico and South Carolina.
› Verified 9 days ago
Micholee Beth Polsak, DO Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, 6040 Delp, Ms 1020, Kansas University Physicians Inc, Kansas City, KS 66160 Phone: 913-588-3974 Fax: 913-588-6055 | |
Ira William Marsh, MD Geriatric Medicine Medicare: May Accept Medicare Assignments Practice Location: 8929 Parallel Pkwy, Kansas City, KS 66112 Phone: 913-596-4000 | |
Dr. Tara L Lin, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-6030 Fax: 913-588-4085 | |
Kristin N Fee, D.O. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd # Ms 2027, Kansas City, KS 66160 Phone: 913-588-3974 Fax: 913-588-6055 | |
Donald J. Mcsweyn, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 8919 Parallel Pkwy, Suite 580, Kansas City, KS 66112 Phone: 913-596-7224 Fax: 913-596-7257 | |
Dr. Dhanunjaya Lakkireddy, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Suite#g600, Kansas City, KS 66160 Phone: 913-588-9600 Fax: 913-588-9770 | |
Archana Pareek, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, 6040 Delp, Ms 1020, Division Of General And Geriatric Medicine, University, Kansas City, KS 66160 Phone: 913-588-6005 Fax: 913-588-3877 |